Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD Jul 12, 2021
The Latest On Psybio Therapeutics: CEO Evan Levine Comments On Maxim Group Buy Rating, European Research, And More Jul 6, 2021
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Charting Its Own Course in Psychedelic Space Jun 30, 2021
COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb… Jun 28, 2021
